Posts

Advancements in Breast-Conserving Treatment: Insights from Monica Morrow

WCLC 2023 | Dr. Harpole: Surgical outcomes from AEGEAN trial and subgroup analyses of patients who were EGFR-mutant

WCLC 2023 | Dr. Drilon: Advances in MET Target therapy released in 2023 WCLC

WCLC 2023 | Acceptance Speech by 2023 Distinguished Service Award Winner Dr. Ramalingam

WCLC 2023 |Dr. Reguart reviews three important small cell lung cancer immunotherapy studies

WCLC 2023 | Talking with the co-chairs Dr. Hegi-Johnson about the theme and important issues

WCLC 2023 |Dr. Gainor reviews IMpower151: Is the high percentage of patients with EGFR mutations, the reason for the research’s failure ?

WCLC 2023 | Talking with Dr. Bestvina about MA16 - Innovations in the Treatment of Stage III NSCLC

WCLC 2023 | Dr. Liu：Chemo-immunotherapy offers long-term survival benefit for ES-SCLC patients

WCLC 2023 | Dr. Johnson：Antibody Drug Conjugate (ADC) targeting B7-H3 shows efficient and durable efficacy in patients with refractory SCLC

de-escalation and escalation treatment of early breast cancer—Interview with Giuseppe Curigliano at SGBCC 2023

surgery of the primary for stage IV disease—Interview with William Gradishar at SGBCC 2023

Do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)

An interview with Professor Masatoshi Kudo - Interpreting Final analysis of RATIONALE-301

ESMO 2022丨Interview with Professor Andrés Cervantes: See you in Madrid